299 related articles for article (PubMed ID: 16341044)
81. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.
Young RM; Hardy IR; Clarke RL; Lundy N; Pine P; Turner BC; Potter TA; Refaeli Y
Blood; 2009 Mar; 113(11):2508-16. PubMed ID: 18981293
[TBL] [Abstract][Full Text] [Related]
82. Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG).
Ohki K; Kiyokawa N; Watanabe S; Iwafuchi H; Nakazawa A; Ishiwata K; Ogata-Kawata H; Nakabayashi K; Okamura K; Tanaka F; Fukano R; Hata K; Mori T; Moriya Saito A; Hayashi Y; Taga T; Sekimizu M; Kobayashi R;
Br J Haematol; 2021 Aug; 194(4):718-729. PubMed ID: 34258755
[TBL] [Abstract][Full Text] [Related]
83. Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies.
Geissinger E; Bonzheim I; Krenács L; Roth S; Ströbel P; Ott G; Reimer P; Wilhelm M; Müller-Hermelink HK; Rüdiger T
J Mol Diagn; 2005 Oct; 7(4):455-64. PubMed ID: 16237215
[TBL] [Abstract][Full Text] [Related]
84. CD52 expression in peripheral T-cell lymphomas determined by combined immunophenotyping using tumor cell specific T-cell receptor antibodies.
Geissinger E; Bonzheim I; Roth S; Rosenwald A; Müller-Hermelink HK; Rüdiger T
Leuk Lymphoma; 2009 Jun; 50(6):1010-6. PubMed ID: 19479612
[TBL] [Abstract][Full Text] [Related]
85. Nodal marginal zone B-cell lymphoma with a novel t(X;5)(q28;q22): conventional and molecular cytogenetic analysis.
Cook JR; Sherer ME; Shekhter-Levin S; Swerdlow SH
Cancer Genet Cytogenet; 2003 Jun; 143(2):154-9. PubMed ID: 12781450
[TBL] [Abstract][Full Text] [Related]
86. Localization of the human IL-2-inducible T-cell kinase gene (ITK) to chromosome band 5q34 and the mouse gene (Itk) to chromosome 15 by fluorescence in situ hybridization.
Tate G; Okuyama M; Okamoto M; Futaki G; Kimura S; Endo Y; Mitsuya T; Katagiri M
Cytogenet Cell Genet; 1996; 74(1-2):96-8. PubMed ID: 8893810
[TBL] [Abstract][Full Text] [Related]
87. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.
Cortes JR; Filip I; Albero R; Patiño-Galindo JA; Quinn SA; Lin WW; Laurent AP; Shih BB; Brown JA; Cooke AJ; Mackey A; Einson J; Zairis S; Rivas-Delgado A; Laginestra MA; Pileri S; Campo E; Bhagat G; Ferrando AA; Rabadan R; Palomero T
Cell Rep; 2022 Apr; 39(3):110695. PubMed ID: 35443168
[TBL] [Abstract][Full Text] [Related]
88. Chromosomal location of the Syk and ZAP-70 tyrosine kinase genes in mice and humans.
Ku G; Malissen B; Mattei MG
Immunogenetics; 1994; 40(4):300-2. PubMed ID: 8082894
[No Abstract] [Full Text] [Related]
89. Tyrosine kinases in nodal peripheral T-cell lymphomas.
Piccaluga PP; Cascianelli C; Inghirami G
Front Oncol; 2023; 13():1099943. PubMed ID: 36845713
[TBL] [Abstract][Full Text] [Related]
90. Peripheral T-cell lymphoma involving the placenta.
Kurtin PJ; Gaffey TA; Habermann TM
Cancer; 1992 Dec; 70(12):2963-8. PubMed ID: 1333356
[TBL] [Abstract][Full Text] [Related]
91. Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases.
Gaulard P; Kanavaros P; Farcet JP; Rocha FD; Haioun C; Divine M; Reyes F; Zafrani ES
Hum Pathol; 1991 Apr; 22(4):331-8. PubMed ID: 2050367
[TBL] [Abstract][Full Text] [Related]
92. Molecular Insights Into Pathogenesis of Peripheral T Cell Lymphoma: a Review.
Lone W; Alkhiniji A; Manikkam Umakanthan J; Iqbal J
Curr Hematol Malig Rep; 2018 Aug; 13(4):318-328. PubMed ID: 29951889
[TBL] [Abstract][Full Text] [Related]
93. Peripheral T-cell lymphoma in lckpr-bcl-2 transgenic mice.
Linette GP; Hess JL; Sentman CL; Korsmeyer SJ
Blood; 1995 Aug; 86(4):1255-60. PubMed ID: 7632929
[TBL] [Abstract][Full Text] [Related]
94. Chromosomal translocations involved in non-Hodgkin lymphomas.
Vega F; Medeiros LJ
Arch Pathol Lab Med; 2003 Sep; 127(9):1148-60. PubMed ID: 12946230
[TBL] [Abstract][Full Text] [Related]
95. Peripheral T cell lymphoma in Asia.
Park S; Ko YH
Int J Hematol; 2014 Mar; 99(3):227-39. PubMed ID: 24481942
[TBL] [Abstract][Full Text] [Related]
96. Paracortical nodular T-cell lymphoma. Identification of an unusual variant of peripheral T-cell lymphoma.
Macon WR; Williams ME; Greer JP; Cousar JB
Am J Surg Pathol; 1995 Mar; 19(3):297-303. PubMed ID: 7872427
[TBL] [Abstract][Full Text] [Related]
97. Classification of peripheral T-cell lymphomas: cytogenetic findings support the updated Kiel classification.
Schlegelberger B; Feller AC
Leuk Lymphoma; 1996 Feb; 20(5-6):411-6. PubMed ID: 8833396
[TBL] [Abstract][Full Text] [Related]
98. HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2).
Morerio C; Acquila M; Rosanda C; Rapella A; Dufour C; Locatelli F; Maserati E; Pasquali F; Panarello C
Cancer Res; 2004 Apr; 64(8):2649-51. PubMed ID: 15087372
[TBL] [Abstract][Full Text] [Related]
99. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
Wang T; Feldman AL; Wada DA; Lu Y; Polk A; Briski R; Ristow K; Habermann TM; Thomas D; Ziesmer SC; Wellik LE; Lanigan TM; Witzig TE; Pittelkow MR; Bailey NG; Hristov AC; Lim MS; Ansell SM; Wilcox RA
Blood; 2014 May; 123(19):3007-15. PubMed ID: 24497534
[TBL] [Abstract][Full Text] [Related]
100. Pathology of peripheral T-cell lymphomas: where do we stand?
Gaulard P; de Leval L
Semin Hematol; 2014 Jan; 51(1):5-16. PubMed ID: 24468311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
